Dr. Narendra Agrawal

MBBS, MD, DM (Clinical Hematology- AIIMS)

Sr. Consultant – Hemato Oncology & Bone Marrow Transplant

Book an Appointment

RGCIRC, Rohini, Delhi - 110 085

About

Dr. Narendra Agrawal is a highly skilled Clinical Hematologist with extensive experience in the diagnosis and treatment of blood disorders. He earned his DM in Clinical Hematology from the prestigious All India Institute of Medical Sciences (AIIMS), Delhi, in 2011. His journey in hematology began in 2007 with training at SGPGIMS, Lucknow, followed by AIIMS, Delhi. Since January 2012, he has been serving as a Consultant at RGCIRC, where he specializes in treating patients with blood cancers, anemia, thalassemia, and bleeding disorders. Beyond his clinical expertise, Dr. Agrawal is deeply involved in academic activities, postgraduate teaching, and research. His contributions to the field include numerous scientific publications in esteemed national and international journals, as well as presentations at international forums. Additionally, he plays a key role in training and education at RGCIRC, serving as a coordinator and tutor for the PICC Training Program and the Bone Marrow Biopsy Training Program.

Specialized Areas

Allogeneic bone marrow/ stem cell transplantation
Haplo-identical bone marrow/ stem cell transplantation
Autologous bone marrow/ stem cell transplantation
Blood cancers like acute leukemia (AML, ALL), lymphoma, myeloma, myelodysplastic syndromes
Blood diseases like anemia, aplastic anemia, bleeding disorders (eg ITP), coagulation disorder (eg DVT)
Congenital blood disorders like Thalassemia and other hemoglobinopathies, Hemophilia

Educational Background

D.M. (Hematology), All India Institute of Medical Sciences, Delhi
M.D, Jawahar Lal Nehru Medical College, Ajmer, Rajasthan (University of Rajasthan)
M.B.B.S, Ravindra Nath Tagore Medical College, Udaipur, Rajasthan (University of Rajasthan)

Experience

Consultant, RGCIRC, Delhi: 2012 – till date
Research and clinical trials in such areas as AML, DVT, ALL, BMT, Lymphoma and Myeloma, ITP
Teaching experience in clinical hematology, 2007
Experience in hematology and bone marrow transplantation, 2007
Clinical experience, 2000

Professional Journey

PUBLICATION

Publications: His main area of research and publications has been acute lymphoblastic leukemia (ALL) and Multiple Myeloma. From a large list of his research publications, few notable publications are

Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D. Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1): e2015013. doi: 10.4084/MJHID.2015.013.
Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, Bhurani D. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transplant Infectious Disease. 2018 Feb;20(1): e12794.
Aggarwal M, Agrawal N, Yadav N, Verma P, Ahmed R, Mehta P, Kapoor J, Bhurani D. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Annals of Hematology. 2018 May 21:1-9.
Agrawal N, Verma P, Yadav N, Ahmed R, Mehta P, Soni P, Francis S, Bhurani D. Outcome of Philadelphia Positive Acute Lymphoblastic LeukemiaWith or Without Allogeneic Stem Cell Transplantation in a Retrospective Study. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):240-7.
Agrawal N, Yadav N, Verma P, Soni P, Mehta P, Thekkudan SF, Ahmed R, Bhurani D. Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblastic Leukemia. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):357-9.
Kapoor J, Pramanik SK, Agrawal P, Khushoo V, Naim F, Mirgh SP, Ahmed R, Bhurani D, Agrawal N. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplantation. 2020 Apr 14:1-3
Vivek Radhakrishnan, Narendra Agrawal, Bhausaheb Bagal, Ishan Patel; Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy. Clinical Lymphoma, Myeloma and Leukemia (2020), doi: https://doi.org/10.1016/j.clml.2020.08.023
Tribikram Panda, Sujay Rainchwar, Reema Singh, Aakanksha Singh, Mayank Soni, Disha Kakkar, KR Jegan, Reshmi Harikumar Pillai, Roy J.Palatty, Karuna Jha, Rayaz Ahmed, Rohan Halder, Narender Tejwani, Devasis Panda, Dinesh Bhurani, Narendra Agrawal, Real World Outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in Adolescents and Adults Treated with Intensive Regimes. Leukemia ResearchVolume 141, June 2024, 107506. https://doi.org/10.1016/j.leukres.2024.107506